PEAK1 and breast carcinoma: These data were further supported by analyzing the expression of PEAK1 across a subset of patient-derived cancer-associated fibroblasts (CAFs) (i.e., two from each breast cancer subtype) previously isolated and transcriptomically profiled [30] (Fig. 2f).